| Dr Jeffrey Virgil Wilde, MD | |
|
302 El Camino Real Bldg 11, Sierra Vista, AZ 85635-2860 | |
| (520) 255-5475 | |
| (855) 801-7998 |
| Full Name | Dr Jeffrey Virgil Wilde |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 302 El Camino Real Bldg 11, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073703310 | NPI | - | NPPES |
| 613078 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 44157 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Canyon Vista Medical Center | Sierra vista, AZ | Hospital |
| Copper Queen Community Hospital | Bisbee, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jeffrey Wilde Md Pllc | 6901138049 | 4 |
News Archive
International researchers have developed a prediction model to assist doctors in determining the chance of recurrence of cancer in high-risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
Hot weather and diabetes can make for a potentially dangerous combination, according to a Mayo Clinic presentation at the 92nd Annual Meeting of the Endocrine Society in San Diego, California, June 19-22.
The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.
Cord Blood America, Inc., announced today its stem cell processing and storage subsidiary, CorCell, is launching "Afford-A-Cord," which reduces the initial cost of storing umbilical cord blood stem cells from $2075 to $495 plus medical courier service. The Afford-A-Cord program will be offered as an additional payment option to CorCell's long standing traditional payment programs.
› Verified 7 days ago
| Entity Name | Jeffrey Wilde Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518515683 PECOS PAC ID: 6901138049 Enrollment ID: O20191023000751 |
News Archive
International researchers have developed a prediction model to assist doctors in determining the chance of recurrence of cancer in high-risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
Hot weather and diabetes can make for a potentially dangerous combination, according to a Mayo Clinic presentation at the 92nd Annual Meeting of the Endocrine Society in San Diego, California, June 19-22.
The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.
Cord Blood America, Inc., announced today its stem cell processing and storage subsidiary, CorCell, is launching "Afford-A-Cord," which reduces the initial cost of storing umbilical cord blood stem cells from $2075 to $495 plus medical courier service. The Afford-A-Cord program will be offered as an additional payment option to CorCell's long standing traditional payment programs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Virgil Wilde, MD 302 El Camino Real Bldg 11, Sierra Vista, AZ 85635-2860 Ph: (520) 255-5475 | Dr Jeffrey Virgil Wilde, MD 302 El Camino Real Bldg 11, Sierra Vista, AZ 85635-2860 Ph: (520) 255-5475 |
News Archive
International researchers have developed a prediction model to assist doctors in determining the chance of recurrence of cancer in high-risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
Hot weather and diabetes can make for a potentially dangerous combination, according to a Mayo Clinic presentation at the 92nd Annual Meeting of the Endocrine Society in San Diego, California, June 19-22.
The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.
Cord Blood America, Inc., announced today its stem cell processing and storage subsidiary, CorCell, is launching "Afford-A-Cord," which reduces the initial cost of storing umbilical cord blood stem cells from $2075 to $495 plus medical courier service. The Afford-A-Cord program will be offered as an additional payment option to CorCell's long standing traditional payment programs.
› Verified 7 days ago
Ralph Esker Mayberry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Wilcox Dr, Sierra Vista, AZ 85635 Phone: 520-459-3116 Fax: 520-459-7397 | |
Dr. Franklin Terry Perkins Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3533 Canyon De Flores Ste A, Sierra Vista, AZ 85650 Phone: 520-685-3336 | |
Dr. Parag Rasik Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 126 S Coronado Dr, Suite B, Sierra Vista, AZ 85635 Phone: 520-439-0115 Fax: 520-458-3016 | |
Louise Nosanchuck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 77 E Fry Blvd, Sierra Vista, AZ 85635 Phone: 520-459-8915 Fax: 520-458-9424 | |
Mark Christian Carnett, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Calle Portal, Suite 600, Sierra Vista, AZ 85635 Phone: 520-439-5186 Fax: 520-439-4466 | |
Dr. Natalie Rose Krumdieck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Calle Portal Ste 300, Sierra Vista, AZ 85635 Phone: 520-459-3011 Fax: 520-364-4261 |